1. FRI0026 PROTEOMICS ANALYSIS COMPARING THE MODE OF ACTION OF UPADACITINIB AND ADALIMUMAB HEAD TO HEAD IN RA IDENTIFIES NOVEL, DISCRETE EARLY IMMUNE PATHWAY MODULATION IN THE SELECT-COMPARE PHASE 3 STUDY. (2nd June 2020) Authors: Sornasse, T.; Song, I. H.; Radstake, T.; Mcinnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0131 SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE. (2nd June 2020) Authors: Nash, P.; Kavanaugh, A.; Buch, M. H.; Combe, B.; Bessette, L.; Song, I. H.; Song, Y.; Suboticki, J.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0138 THE IMPACT OF UPADACITINIB VERSUS METHOTREXATE OR ADALIMUMAB ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Van Vollenhoven, R.; Ostor, A.; Mysler, E.; Damjanov, N.; Song, I. H.; Song, Y.; Suboticki, J.; Strand, V. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY. (2nd June 2020) Authors: Fleischmann, R.; Song, I. H.; Enejosa, J.; Mysler, E.; Bessette, L.; Durez, P.; Ostor, A.; Swierkot, J.; Song, Y.; Genovese, M. C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0207 SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS. (2nd June 2020) Authors: Kavanaugh, A.; Buch, M. H.; Combe, B.; Bessette, L.; Song, I. H.; Song, Y.; Suboticki, J.; Nash, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0211 RADIOGRAPHIC OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE: RESULTS AT 2 YEARS FROM THE SELECT-COMPARE AND SELECT-EARLY STUDIES. (2nd June 2020) Authors: Peterfy, C.; Strand, V.; Genovese, M. C.; Friedman, A.; Enejosa, J. J.; Hall, S.; Mysler, E.; Durez, P.; Baraliakos, X.; Shaw, T.; Song, Y.; Li, Y.; Song, I. H. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0375 IMPROVEMENTS IN GLOBAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED WITH UPADACITINIB: RESULTS FROM THE SELECT-AXIS 1 TRIAL. (2nd June 2020) Authors: Kiltz, U.; Sieper, J.; Deodhar, A.; Zueger, P.; Song, I. H.; Chen, N.; Van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗